- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09:31 | GREAT WORLD (08003): NOTIFICATION OF BOARD MEETING- TO BE HELD ON 27 NOVEMBER 2025 | ||
| 09:30 | ZHIDA TECH (02650): END OF STABILISATION PERIOD, NO STABILISATION ACTION AND LAPSE OF OVER-ALLOTMENT OPTION | ||
| 09:30 | VOBILE GROUP (03738): UNAUDITED OPERATING DATA FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2025 | ||
| 09:20 | TRIGIANT (01300): NEXT DAY DISCLOSURE RETURN | ||
| 08:38 | STANCHART (02888): TRANSACTION IN OWN SHARES | ||
| 06:34 | GENES TECH (08257): TRADING HALT | ||
| 06:01 | XINXIANGERA-NEW (08519): NEXT DAY DISCLOSURE RETURN | ||
| 05:20 | VIGONVITA-B (02630): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | ||
| 05:14 | VIGONVITA-B (02630): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS | ||
| 05:14 | HKEX (00388): QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2025 | ||
| 05:11 | VIGONVITA-B (02630): TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD OF DIRECTORS | ||
| 05:09 | MMG (01208): VOLUNTARY ANNOUNCEMENT - EUROPEAN COMMISSION PHASE II REVIEW | ||
| 05:08 | VIGONVITA-B (02630): TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS | ||
| 05:06 | VIGONVITA-B (02630): ARTICLES OF ASSOCIATION | ||
| 05:02 | CT IND GROUP (08111): NOTICE OF BOARD MEETING | ||
| 05:01 | SWHYHK (00218): LIST OF DIRECTOR AND THEIR ROLE AND FUNCTION | ||
| 05:01 | SWHYHK (00218): CANCELLATION OF THE EXECUTIVE COMMITTEE | ||
| 05:00 | CHI KINGSTONE (01380): CHANGE OF COMPANY LOGO | ||
| 05:00 | XIAOCAIYUAN (00999): CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG | ||
| 01:08 | STANCHART (02888): ISSUANCE OF U.S.$1,000,000,000 FIXED RATE RESETTING PERPETUAL SUBORDINATED CONTINGENT CONVERTIBLE SECURITIES | ||
| 01:02 | HUTCHMED (00013): VOLUNTARY ANNOUNCEMENT - HUTCHMED ANNOUNCES ENROLLMENT COMPLETED OF SAFFRON GLOBAL PHASE III TRIAL OF ORPATHYS AND TAGRISSO COMBINATION ... | ||
| 01:00 | JBM HEALTHCARE (02161): DATE OF BOARD MEETING | ||
| 01:00 | ASCLETIS-B (01672): VOLUNTARY ANNOUNCEMENT - ASCLETIS PRESENTS FULL ANALYSIS OF PHASE IB STUDY OF ASC30 ORAL TABLET, PHASE IB STUDY OF ASC30 INJECTION, ... | ||
| 00:40 | ZAI LAB (09688): INSIDE INFORMATION - UPDATE ON AMGEN'S BEMARITUZUMAB PHASE 1B/3 FORTITUDE-102 STUDY | ||
| 00:34 | PONY-W (02026): COMPANY INFORMATION SHEET |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .